News for hackers. Stuff that matters.

A comment on FDA promised a ‘lower-cost option’ to EpiPen, but the price isn’t any lower. Parent comment

Re:FDA promised a ‘lower-cost option’ to EpiPen, but the pri... by Retric on Wednesday November 28, 2018 @01:27PM (#18554167)
The list prices hold up better without this competition. So, the actual price people pay for either drops even when the genric version has a very similar list price.

However, it drops even more in 180 days.

[ Parent | on HN ]

There are no comments on this comment yet.